Diagnostic pitfalls in patients referred for arrhythmogenic right ventricular cardiomyopathy

被引:4
作者
Sampognaro, James R. [1 ]
Gaine, Sean P. [1 ]
Sharma, Apurva [1 ]
Tichnell, Crystal [1 ]
Murray, Brittney [1 ]
Shaik, Zeba [1 ]
Zimmerman, Stefan L. [1 ]
James, Cynthia A. [1 ]
Gasperetti, Alessio [1 ]
Calkins, Hugh [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, 600 N Wolfe St, Baltimore, MD 21287 USA
关键词
Arrhythmogenic right ventricular cardiomyopathy; Cardiac magnetic resonance imaging; Implantable cardioverter-defibrillator; Misdiagnosis; Task Force Criteria; CARDIAC SARCOIDOSIS; FOLLOW-UP; DYSPLASIA/CARDIOMYOPATHY; GENETICS; IMPACT;
D O I
10.1016/j.hrthm.2023.08.035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND The diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC) is challenging because of nonspecific clinical findings and lack of conclusive answers from genetic testing (ie, an ARVC-related variant is neither necessary nor sufficient for diagnosis). Despite the revised 2010 Task Force Criteria, patients are still misdiagnosed with ARVC. OBJECTIVE In patients referred for ARVC, we sought to identify the clinical characteristics and diagnostic confounders for those patients in whom ARVC was ultimately ruled out. METHODS Patients who were referred to our center with previously diagnosed or suspected ARVC (between January 2011 and September 2019; N = 726) were included in this analysis. RESULTS Among 726 patients, ARVC was ruled out in 365 (50.3%). The most common presenting symptoms in ruled-out patients were palpitations (n = 139, 38.1%), ventricular arrhythmias (n = 62, 17.0%), and chest pain (n = 53, 14.5%). On the basis of outside evaluation, 23.8% of these patients had received implantable cardioverter-defibrillators (ICDs) and device extraction was recommended in 9.0% after reevaluation. An additional 5.5% had received ICD recommendations, all of which were reversed on reevaluation. The most frequent final diagnoses were idiopathic premature ventricular contractions/ventricular tachycardia/ventricular fibrillation (46.6%), absence of disease (19.2%), and noncardiac presyncope/syncope (17.5%). The most common contributor to diagnostic error was cardiac magnetic resonance imaging, including mistaken right ventricular wall motion abnormalities (33.2%) and nonspecific fat (12.1%). CONCLUSION False suspicion or misdiagnosis was found in the majority of patients referred for ARVC, resulting in inappropriate ICD implantation or recommendation in 14.5% of these patients. Misdiagnosis or false suspicion was most commonly due to misinterpretation of cardiac magnetic resonance imaging.
引用
收藏
页码:1720 / 1726
页数:7
相关论文
共 50 条
  • [21] Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia/cardiomyopathy patient
    Wang, Weijia
    James, Cynthia A.
    Calkins, Hugh
    EUROPACE, 2019, 21 (01): : 9 - 21
  • [22] Arrhythmogenic right ventricular cardiomyopathy: From genetics to diagnostic and therapeutic challenges
    Pinamonti, Bruno
    Brun, Francesca
    Mestroni, Luisa
    Sinagra, Gianfranco
    WORLD JOURNAL OF CARDIOLOGY, 2014, 6 (12): : 1234 - 1244
  • [23] Characterisation of patients referred to a tertiary-level inherited cardiac condition clinic with suspected arrhythmogenic right ventricular cardiomyopathy (ARVC)
    Aljehani, A.
    Kew, T.
    Baig, S.
    Cox, H.
    Sommerfeld, L. C.
    Ensam, B.
    Kalla, M.
    Steeds, R. P.
    Fabritz, L.
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [24] Arrhythmogenic right ventricular cardiomyopathy - An update
    Peters, S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 172 (02) : E375 - E376
  • [25] Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation
    Kirubakaran, Senthil
    Bisceglia, Caterina
    Silberbauer, John
    Oloriz, Teresa
    Santagostino, Giulia
    Yamase, Miki
    Maccabelli, Giuseppe
    Trevisi, Nicola
    Della Bella, Paolo
    EUROPACE, 2017, 19 (06): : 1049 - 1062
  • [26] Clinical and Genetic Characteristics of Arrhythmogenic Right Ventricular Cardiomyopathy Patients: A Single-Center Experience
    Al-Ghamdi, Bandar Saeed
    Alhadeq, Faten
    Alqahtani, Aisha
    Alruwaili, Nadiah
    Rababh, Monther
    Alghamdi, Sara
    Almanea, Waleed
    Alhassnan, Zuhair
    CARDIOLOGY RESEARCH, 2023, 14 (05) : 379 - 386
  • [27] Current Concepts on Diagnosis and Prognosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
    Gutierrez, Sandra L. Castanos
    Kamel, Ihab R.
    Zimmerman, Stefan L.
    JOURNAL OF THORACIC IMAGING, 2016, 31 (06) : 324 - 335
  • [28] Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy
    Gasperetti, Alessio
    James, Cynthia A.
    Carrick, Richard T.
    Protonotarios, Alexandros
    te Riele, Anneline S. J. M.
    Cadrin-Tourigny, Julia
    Compagnucci, Paolo
    Duru, Firat
    van Tintelen, Peter
    Elliot, Perry M.
    Calkins, Hugh
    EUROPACE, 2023, 25 (11):
  • [29] Transvenous Lead Extraction in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy
    Barakat, Amr F.
    Zmaili, Mohammad A.
    Tarakji, Khaldoun G.
    Shah, Shailee
    Rehman, Karim Abdur
    Martin, David O.
    Brunner, Michael P.
    Saliba, Walid, I
    Kanj, Mohamed
    Ballout, Jad
    Baranowski, Bryan
    Cantillon, Daniel
    Niebauer, Mark
    Callahan, Thomas
    Dresing, Thomas
    Rickard, John
    Lindsay, Bruce D.
    Wilkoff, Bruce L.
    Wazni, Oussama M.
    Hussein, Ayman A.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2019, 5 (06) : 665 - 670
  • [30] Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis
    Haugaa, Kristina H.
    Haland, Trine F.
    Leren, Ida S.
    Saberniak, Jorg
    Edvardsen, Thor
    EUROPACE, 2016, 18 (07): : 965 - 972